GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BiOptic Inc (ROCO:6850) » Definitions » Accounts Payable & Accrued Expense

BiOptic (ROCO:6850) Accounts Payable & Accrued Expense : NT$35.1 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is BiOptic Accounts Payable & Accrued Expense?

BiOptic's quarterly accounts payable & accrued expense declined from Jun. 2023 (NT$83.1 Mil) to Dec. 2023 (NT$66.9 Mil) and declined from Dec. 2023 (NT$66.9 Mil) to Jun. 2024 (NT$35.1 Mil).

BiOptic's annual accounts payable & accrued expense increased from Dec. 2021 (NT$36.3 Mil) to Dec. 2022 (NT$75.7 Mil) but then declined from Dec. 2022 (NT$75.7 Mil) to Dec. 2023 (NT$66.9 Mil).

BiOptic Accounts Payable & Accrued Expense Historical Data

The historical data trend for BiOptic's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BiOptic Accounts Payable & Accrued Expense Chart

BiOptic Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial 10.48 20.21 36.27 75.68 66.87

BiOptic Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 61.62 75.68 83.13 66.87 35.13

BiOptic Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

BiOptic Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BiOptic Inc (ROCO:6850) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
ROCO:6872 ROCO:3205 ROCO:6810 ROCO:6610 ROCO:6709 ROCO:6827 ROCO:4192 ROCO:4186 ROCO:4195 ROCO:6652 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
No 6, Ln, 130 Minquan Road, 5th Floor, Hsin- Tien District, New Taipei, TWN, 23141
Website
https://www.bioptic.com
BiOptic Inc is a biotechnology instrumentation company that develops innovative scientific products for research and clinical applications. It serves professionals and laboratories dedicated to life science research, clinical diagnostics, pharmaceutical and food industries, animal husbandry and agriculture, performing diagnostic molecular genetic analyses.

BiOptic Headlines

No Headlines